Velopharyngeal Insufficiency After Botox Injection for Persistent Bruxism.
| Autor: | Evin N; Department of Plastic, Reconstructive and Aesthetic Surgery, Bezmialem Vakif University., Sifil MK; Istanbul Provincial Health Directorate., Aghazada TM; Private Practice, Istanbul, Turkey., Özcan ED; Department of Plastic and Reconstructive Surgery, Carol Davila University of Medicine, Bucharest, Romania., Guneren E; Department of Plastic, Reconstructive and Aesthetic Surgery, Bezmialem Vakif University. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | The Journal of craniofacial surgery [J Craniofac Surg] 2024 Mar-Apr 01; Vol. 35 (2), pp. 495-497. Date of Electronic Publication: 2023 Oct 10. |
| DOI: | 10.1097/SCS.0000000000009769 |
| Abstrakt: | Botulinum toxin type-A (BTX-A) injections have emerged as a promising treatment for bruxism and temporomandibular joint (TMJ) disorders. However, there is a need for further exploration of optimal dosage, injection techniques, and intervals to maximize treatment effectiveness. Complications, such as velopharyngeal insufficiency, can occur after BTX-A injections, emphasizing the importance of precautionary measures. The utilization of ultrasound guidance and electromyography assistance can aid in precise injections and minimize the risk of complications. In addition, patients should receive appropriate medication and adhere to post-treatment instructions to alleviate symptoms. Follow-up procedures are essential to monitor potential complications, and in some cases, professional mental health care may be required. Further research is warranted to establish the safety and efficacy of BTX-A injections for the treatment of bruxism and TMJ disorders. This case study presents the development velopharyngeal insufficiency in a patient with chronic bruxism 3 days after receiving a BTX-A injection. Competing Interests: The authors report no conflicts of interest. (Copyright © 2023 by Mutaz B. Habal, MD.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|